ADDPILL.COM

WELCOME TO ADDPILL.COM

ADDPILL.COM is singular category language: ADD/ADHD + pill—the phrase patients type when comparing stimulant and non-stimulant options in telehealth-to-pharmacy funnels. Brandable category door, not a specific molecule claim or medical advice.

Buyers: telehealth ADHD programs; specialty pharmacy education hubs; adherence and prior-auth tools; publishers comparing formulation options. Exact-fit launch: a “first conversation about ADD pills” explainer at ADDPill.com with clinician-reviewed FAQs.

Demand proof: CDC data show 11.4% of U.S. children ages 3–17 (about 7.1 million) had ever been diagnosed with ADHD as of 2022, and NCHS Rapid Surveys estimated about 15.5 million U.S. adults (6.0%) with current ADHD in late 2023—while ASHP put overall U.S. Rx spending at $915 billion in 2025.^[1][2][3]

Why Choose ADDPILL.COM

• 💊 Singular category cue: ADD pill = one SKU-style conversation starter.
• 🏥 Telehealth-to-Rx fit: Built for education funnels before pharmacy handoff.
• 📋 Not a molecule claim: Category door—no specific drug endorsement.
• 🔬 Vs ADDPills plural: Singular landing vs plural catalog sibling.
• 💡 11.4% of children: CDC ever-diagnosed ADHD ages 3–17 (2022).^[1]
• 🛡️ ~15.5M adults: NCHS/CDC current adult ADHD estimate (2023).^[2]

BUY NOW - $24,000

Buy Now — ADDPILL.COM — lock this ADD / ADHD pill category brandable door for pharmacy-aligned brands.

Purchase ADDPILL.COM today through our trusted partners:

• GoDaddy
• Xela Domains
• Afternic

WHAT DOES ANTHONY IVERSONS THINK?

"ADDPill.com is the singular ADHD pill conversation door—education first, no molecule claims."

Anthony Iversons, Legal Advisor
Contact Anthony Iversons via Email

Related Domains

FAQs

Medical advice?

No—category education domain only; not a prescribing service.

Who buys?

Telehealth ADHD programs, specialty pharmacy educators, adherence tools.

Vs ADDPills.com?

Singular pill conversation vs plural catalog/listing sibling.

Stats?

CDC child prevalence 11.4% (2022); ~15.5M adults (2023); ASHP Rx $915B (2025).

Contact Us

We’re here to help you secure ADDPILL.COM. Contact us today to discuss how this domain can benefit your business. 📬

Email: info@xeladomains.com
Phone: (858) 429-9352

Social Networks

Follow us on Instagram and LinkedIn for updates and more insights into how our domains can serve your business needs.

Instagram | LinkedIn

REFERENCES

1. CDC — ADHD data: 11.4% of U.S. children ages 3–17 ever diagnosed (2022); ~7.1M
2. CDC MMWR — ~15.5 million U.S. adults (6.0%) with current ADHD (Oct–Nov 2023)
3. ASHP via PR Newswire — U.S. Rx spend $915B in 2025 (+12.7%)